Suppr超能文献

定制近红外激活的光笼:后期笼化方案。

Near-Infrared-Activated Photocages Made to Order: Late-Stage Caging Protocol.

作者信息

Russo Marina, Zielinska Dominika, Hanc Katarzyna, Ramundo Andrea, Meier Delia, Szabo Attila, Štacko Peter

机构信息

Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.

出版信息

JACS Au. 2025 May 1;5(6):2632-2640. doi: 10.1021/jacsau.5c00223. eCollection 2025 Jun 23.

Abstract

Nature has perfected the reversible control over the activity of molecules and biomolecules in the human body. Photocages aim to mimic this control in space and time by using light as a trigger, and the field has witnessed many excellent contributions that extend their use to the tissue-penetrating region. Yet little attention has been paid to developing simple caging strategies that are crucial to translating photocages into a widely accepted tool outside the chemistry field. Here, we report a robust and user-friendly protocol that enables the installation of complex amine, thiol, and phenol payloads in a single step under mild conditions and using bench-stable intermediates. The protocol displays excellent compatibility with a range of payloads, manifested by caging hormones, neurotransmitters, a tripeptide, and many highly complex FDA-approved drugs, including antibiotics and anticancer agents. As a proof of concept, we applied this strategy to cage the clinically approved CDK4/6 inhibitor palbociclib and evaluated its near-infrared (NIR) light-dependent activation in modulating tumor-suppressing retinoblastoma protein. We anticipate that this user-friendly synthetic approach to accessing NIR-absorbing photocages will accelerate research across various scientific disciplines.

摘要

自然界已经完美地实现了对人体中分子和生物分子活性的可逆控制。光笼旨在通过利用光作为触发器在空间和时间上模拟这种控制,并且该领域已经见证了许多卓越的贡献,这些贡献将其应用扩展到了组织穿透区域。然而,对于开发简单的笼化策略却很少有人关注,而这些策略对于将光笼转化为化学领域之外被广泛接受的工具至关重要。在此,我们报告了一种稳健且用户友好的方案,该方案能够在温和条件下使用实验室稳定的中间体一步安装复杂的胺、硫醇和酚类负载物。该方案与一系列负载物表现出出色的兼容性,通过对激素、神经递质、三肽以及许多高度复杂的美国食品药品监督管理局(FDA)批准的药物(包括抗生素和抗癌药物)进行笼化得以体现。作为概念验证,我们应用此策略对临床批准的CDK4/6抑制剂哌柏西利进行笼化,并评估了其在调节肿瘤抑制性视网膜母细胞瘤蛋白中的近红外(NIR)光依赖性激活。我们预计这种用于获取近红外吸收光笼的用户友好型合成方法将加速各个科学学科的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b2e/12188420/75ad9cd79c5b/au5c00223_0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验